CIK: 0001855655 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $2,342,122 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NUVL | NUVALENT INC | 5,269,433 | $402,058 | 17.2% | $60.72 | +20.5% | COM | 670703107 |
| ACLX | ARCELLX INC | 4,649,016 | $306,138 | 13.1% | $41.59 | +49.7% | COMMON STOCK | 03940C100 |
| — | MERUS N V | 4,281,954 | $225,231 | 9.6% | $50.43 | — | COM | N5749R100 |
| RVMD | REVOLUTION MEDICINES INC | 6,093,291 | $224,172 | 9.6% | $36.46 | +5.4% | COM | 76155X100 |
| TARS | TARSUS PHARMACEUTICALS INC | 2,976,099 | $120,562 | 5.1% | $28.61 | +57.3% | COM | 87650L103 |
| PCVX | VAXCYTE INC | 3,372,837 | $109,651 | 4.7% | $59.08 | -44.5% | COM | 92243G108 |
| ONC | BEONE MEDICINES LTD | 347,787 | $84,189 | 3.6% | $203.25 | — | SPONSORED ADS | 07725L102 |
| EWTX | EDGEWISE THERAPEUTICS INC | 6,142,344 | $80,526 | 3.4% | $20.10 | -28.3% | COM | 28036F105 |
| COGT | COGENT BIOSCIENCES INC | 10,352,449 | $74,331 | 3.2% | $7.69 | -27.9% | COM | 19240Q201 |
| JANX | JANUX THERAPEUTICS INC | 2,920,258 | $67,458 | 2.9% | $48.02 | -45.1% | COM | 47103J105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 2,343,553 | $67,401 | 2.9% | $26.38 | +17.1% | COM | 22663K107 |
| IRON | DISC MEDICINE INC | 1,210,971 | $64,133 | 2.7% | $48.64 | -3.4% | COM | 254604101 |
| SRRK | SCHOLAR ROCK HLDG CORP | 1,600,554 | $56,692 | 2.4% | $31.39 | 0.0% | COM | 80706P103 |
| LENZ | LENZ THERAPEUTICS INC | 1,717,066 | $50,327 | 2.1% | $27.56 | -1.3% | COM | 52635N103 |
| BBIO | BRIDGEBIO PHARMA INC | 965,764 | $41,702 | 1.8% | $36.37 | 0.0% | COM | 10806X102 |
| APGE | APOGEE THERAPEUTICS INC | 958,630 | $41,633 | 1.8% | $48.22 | -21.1% | COM | 03770N101 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 878,323 | $41,457 | 1.8% | $46.53 | -12.5% | CLASS A ORD | 61559X104 |
| ALKS | ALKERMES PLC | 1,375,569 | $39,355 | 1.7% | $29.76 | 0.0% | SHS | G01767105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,741,576 | $38,327 | 1.6% | $17.86 | -24.0% | COM | 92790C104 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1,142,511 | $38,000 | 1.6% | $30.31 | 0.0% | COM | 00847X104 |
| OCUL | OCULAR THERAPEUTIX INC | 3,420,340 | $31,741 | 1.4% | $7.77 | +0.7% | COM | 67576A100 |
| OLMA | OLEMA PHARMACEUTICALS INC | 6,764,172 | $28,815 | 1.2% | $8.25 | -46.0% | COM | 68062P106 |
| SYRE | SPYRE THERAPEUTICS INC | 1,870,445 | $28,001 | 1.2% | $26.04 | -43.2% | COM NEW | 00773J202 |
| — | Y-MABS THERAPEUTICS INC | 4,236,346 | $19,106 | 0.8% | $14.19 | — | COM | 984241109 |
| PHVS | PHARVARIS N V | 1,062,911 | $18,707 | 0.8% | $16.11 | 0.0% | COM | N69605108 |
| IMTX | IMMATICS N.V | 3,144,157 | $16,916 | 0.7% | $7.95 | -37.6% | SHS | N44445109 |
| ERAS | ERASCA INC | 11,907,182 | $15,122 | 0.6% | $2.27 | -41.1% | COM | 29479A108 |
| CBIO | CRESCENT BIOPHARMA INC. | 642,721 | $10,374 | 0.4% | $21.15 | 0.0% | COM | G2545C104 |